Accretion Pharmaceuticals Performance
- Today's Low
- ₹162
- Today's High
- ₹167
- 52 Week Low
- ₹54
- 52 Week High
- ₹172
- Open Price₹162
- Previous Close₹170
- Volume4,800
- 50 DMA₹143.90
- 100 DMA₹123.90
- 200 DMA₹103.10
Accretion Pharmaceuticals Chart
Investment Returns
- Over 1 Month + 8.1%
- Over 3 Month + 82.24%
- Over 6 Month + 156.36%
- Over 1 Year + 164.2%
Smart Investing Starts Here Start SIP with Accretion Pharmaceuticals for Steady Growth!
Accretion Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 18.9
- PEG Ratio
- -
- Market Cap Cr
- 183
- P/B Ratio
- 3.3
- Average True Range
- 6.3
- EPS
- 8.7
- Dividend Yield
- 0
- MACD Signal
- 6.3
- RSI
- 58.58
- MFI
- 77.45
Latest Stock News Updates
Accretion Pharmaceuticals shares listed at 79 per share, reflecting a discount of 22 or 21.78 per cent over the issue price of 101 per share
- Business Standard
- 1 year 2 months ago
Accretion Pharmaceuticals Financials
Accretion Pharmaceuticals Technicals
EMA & SMA
- Bearish Moving Average 2
- Bullish Moving Average 14
- 20 Day
- ₹159.30
- 50 Day
- ₹143.90
- 100 Day
- ₹123.90
- 200 Day
- ₹103.10
Resistance and Support
- R3 171.60
- R2 169.30
- R1 166.80
- S1 161.90
- S2 159.60
- S3 157.00
Accretion Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-05-08 | Audited Results & Others | To consider Other business matters. |
| 2025-11-14 | Quarterly Results | |
| 2025-06-10 | Audited Results & Others | To consider Other business matters. |
About Accretion Pharmaceuticals
Accretion Pharmaceuticals is engaged in the business of manufacturing and marketing of Tablets, Capsules, Oral Liquid, External Preparations (Ointment, Cream, Gel, Lotion, Medicated Shampoo, Mouthwash, Dusting Powder), And Oral Powder (Sachet, Dry Syrup) etc. Apart from manufacturing products for direct sales, our Company also manufactures various pharmaceutical products for different marketers on loan license or contract manufacturing basis. Our business is majorly carried out on principal-to-principal basis with different marketers. As on the date of this Red Herring Prospectus, we cater to multiple corporate clients on loan licence and/or contract manufacturing basis. View More- NSE Symbol
- ACCPL
- BSE Symbol
- ISIN
- INE0T8T01010
Similar Stocks to Accretion Pharmaceuticals
Popular Stocks
Accretion Pharmaceuticals FAQs
Accretion Pharmaceuticals share price is ₹164 As on 26 July, 2026 | 03:06
The Market Cap of Accretion Pharmaceuticals is ₹182.5 Cr As on 26 July, 2026 | 03:06
The P/E ratio of Accretion Pharmaceuticals is 18.9 As on 26 July, 2026 | 03:06
The PB ratio of Accretion Pharmaceuticals is 3.3 As on 26 July, 2026 | 03:06
The 52 week High & Low of Accretion Pharmaceuticals is ₹171.8/₹53.8 respectively As on 26 July, 2026 | 03:06
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.